Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (21 ops.)
Latest filing published 04 Jun 2026 for Biomarin Pharmaceutical INC. Read the official filing
Filing timeline
BuySaleTimothy P. Walbert
Insider track record
Disclosed buys
0
Disclosed sells
21
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Timothy P. Walbert: trading record in brief
Timothy P. Walbert is a declared insider at 7 companies (chief executive); the most frequent names are Horizon Therapeutics Public Ltd Co, Egalet Corp and Biomarin Pharmaceutical Inc. In total, 102 filings cover trades dated from 2 January 2016 to 2 June 2026.
Every open-market trade on record is a sale: 21 sales worth €39.6M. Outside the open market, there are 31 share grants and 42 option exercises.
The latest filing, published on 4 June 2026, reports a share grant in Biomarin Pharmaceutical Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Timothy P. Walbert
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations35 total
7,490 shares0Common StockSEC:0001628280-26-040920:0
5,703 sharesCommon StockSEC:0001415889-25-015299:0
6,650 shares0Common StockSEC:0001048477-25-000078:0
3,130 shares0Common StockSEC:0001048477-25-000013:0
616,772 shares@ US$116.5076.4% of flowOrdinary SharesSEC:0001209191-23-052361:0
219,995 sharesOrdinary SharesSEC:0001209191-23-002436:0
15,185 sharesOrdinary SharesSEC:0001209191-23-000918:0
25,000 shares@ US$22.142.4% of flowOrdinary SharesSEC:0001209191-22-034349:0
18,500 shares@ US$92.047.5% of flowOrdinary SharesSEC:0001209191-22-033505:0
25,000 shares@ US$22.142.5% of flowOrdinary SharesSEC:0001209191-22-031126:0
17,600 shares@ US$22.141.8% of flowOrdinary SharesSEC:0001209191-22-028884:0
7,400 shares@ US$22.140.7% of flowOrdinary SharesSEC:0001209191-22-028129:0
13,942 shares@ US$95.386.0% of flowOrdinary SharesSEC:0001209191-22-027083:0
25,000 shares@ US$22.140.6% of flowOrdinary SharesSEC:0001209191-22-025457:0
25,000 shares@ US$22.140.6% of flowOrdinary SharesSEC:0001209191-22-023850:0
14,520 shares@ US$104.611.6% of flowOrdinary SharesSEC:0001209191-22-021969:0
25,000 shares@ US$22.140.6% of flowOrdinary SharesSEC:0001209191-22-021152:0
25,000 shares@ US$22.140.6% of flowOrdinary SharesSEC:0001209191-22-018221:0
25,000 shares@ US$22.140.6% of flowOrdinary SharesSEC:0001209191-22-014100:0
25,000 shares@ US$22.140.6% of flowOrdinary SharesSEC:0001209191-22-008838:0
9,087 shares0Ordinary SharesSEC:0001209191-22-006374:0
25,000 shares@ US$22.140.6% of flowOrdinary SharesSEC:0001209191-22-005676:0
20,336 shares0Ordinary SharesSEC:0001209191-22-004631:0
25,000 shares@ US$22.140.6% of flowOrdinary SharesSEC:0001209191-22-003389:0
241,750 sharesOrdinary SharesSEC:0001209191-22-002282:0
25 of 35 declarations
